ResearchSpace

Synthetic biology meets precision medicine: Drug repurposing for blood cancer precision medicine

Show simple item record

dc.contributor.author Thimiri Govindaraj, Deepak B
dc.date.accessioned 2022-02-27T16:33:54Z
dc.date.available 2022-02-27T16:33:54Z
dc.date.issued 2021-11
dc.identifier.citation Thimiri Govindaraj, D.B. 2021. Synthetic biology meets precision medicine: Drug repurposing for blood cancer precision medicine. <i>Hematology, Transfusion and Cell Therapy, 43(Suppl 3).</i> http://hdl.handle.net/10204/12295 en_ZA
dc.identifier.issn 2531-1379
dc.identifier.uri https://doi.org/10.1016/j.htct.2021.10.1022
dc.identifier.uri http://hdl.handle.net/10204/12295
dc.description.abstract Optimizing Drug discovery and Translation is one of the key tracks in Global Challenges Annual meeting 2019 and is the critical factor in achieving UN Sustainable Development Goals 3 Good Health and Well Being. WHO reports Cancer is the second leading cause of death globally. The aim of the proposal is to establish robust drug screening platform which can identify drugs and drug combinations that are effective in precision medicine for relapsed individual South African Leukemia patients. en_US
dc.format Fulltext en_US
dc.language.iso en en_US
dc.relation.uri https://www.sciencedirect.com/science/article/pii/S253113792101169X?via%3Dihub en_US
dc.source Hematology, Transfusion and Cell Therapy, 43(Suppl 3) en_US
dc.subject Cancer cells en_US
dc.subject Cancer drugs en_US
dc.subject Leukemia patients en_US
dc.title Synthetic biology meets precision medicine: Drug repurposing for blood cancer precision medicine en_US
dc.type Article en_US
dc.description.pages 37-38 en_US
dc.description.note Article published under a Creative Commons license en_US
dc.description.cluster Next Generation Health en_US
dc.description.impactarea Synthetic Nanobiotech Biomachs en_US
dc.identifier.apacitation Thimiri Govindaraj, D. B. (2021). Synthetic biology meets precision medicine: Drug repurposing for blood cancer precision medicine. <i>Hematology, Transfusion and Cell Therapy, 43(Suppl 3)</i>, http://hdl.handle.net/10204/12295 en_ZA
dc.identifier.chicagocitation Thimiri Govindaraj, Deepak B "Synthetic biology meets precision medicine: Drug repurposing for blood cancer precision medicine." <i>Hematology, Transfusion and Cell Therapy, 43(Suppl 3)</i> (2021) http://hdl.handle.net/10204/12295 en_ZA
dc.identifier.vancouvercitation Thimiri Govindaraj DB. Synthetic biology meets precision medicine: Drug repurposing for blood cancer precision medicine. Hematology, Transfusion and Cell Therapy, 43(Suppl 3). 2021; http://hdl.handle.net/10204/12295. en_ZA
dc.identifier.ris TY - Article AU - Thimiri Govindaraj, Deepak B AB - Optimizing Drug discovery and Translation is one of the key tracks in Global Challenges Annual meeting 2019 and is the critical factor in achieving UN Sustainable Development Goals 3 Good Health and Well Being. WHO reports Cancer is the second leading cause of death globally. The aim of the proposal is to establish robust drug screening platform which can identify drugs and drug combinations that are effective in precision medicine for relapsed individual South African Leukemia patients. DA - 2021-11 DB - ResearchSpace DP - CSIR J1 - Hematology, Transfusion and Cell Therapy, 43(Suppl 3) KW - Cancer cells KW - Cancer drugs KW - Leukemia patients LK - https://researchspace.csir.co.za PY - 2021 SM - 2531-1379 T1 - Synthetic biology meets precision medicine: Drug repurposing for blood cancer precision medicine TI - Synthetic biology meets precision medicine: Drug repurposing for blood cancer precision medicine UR - http://hdl.handle.net/10204/12295 ER - en_ZA
dc.identifier.worklist 25374 en_US


Files in this item

Thumbnail
Name: Thimiri Govindara ...
Size: 136.9Kb
Format: PDF
Description: Article
View/Open

This item appears in the following Collection(s)

Show simple item record